🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 24-week study investigating the safety and efficacy of several do...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-28
Trial ID
NCT00111800
Treatments Being Tested
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
UCI Center for Clinical Research
Start Date
2021-06-28
Trial ID
NCT04886518
Treatments Being Tested
The objective of this study is to determine the effect of two dose strength...
Status
Completed
Location
Acorda Site #117
Start Date
2014-12
Trial ID
NCT02271217
Treatments Being Tested
This is a randomized controlled trial employing a Sequential Multiple Assig...
Status
Recruiting
Location
University of California Irvine Medical Center
Start Date
2023-08-29
Trial ID
NCT05975580
Treatments Being Tested
Females are increasingly using cannabis, yet remain underrepresented in pre...
Status
Completed
Location
University of Chicago
Start Date
2018-11-06
Trial ID
NCT03809546
Treatments Being Tested
This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Status
Completed
Location
Thomas Hospital
Start Date
2024-03-01
Trial ID
NCT06264310
Depressed patients will receive 6 weeks of citaloprma (20-40mg) therapy. Su...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00593879
Treatments Being Tested
* Determine whether VI-0521 has an effect on the electrical activity of the...
Status
Completed
Location
MDS Pharma Services
Start Date
2009-02
Trial ID
NCT00839891
Treatments Being Tested
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
This is a Phase 1, two-part, randomized, double blind, placebo controlled, ...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2022-06-07
Trial ID
NCT05364840